The FDA announced a nationwide recall of over 140,000 bottles of a prescription cholesterol medication due to “failed ...

Servier today announced that VORANIGO® (vorasidenib) has been awarded The Galien Foundation's 2025 Prix Galien USA ...

Discover how the Amazon’s purple powerhouse, the açaí berry, is being redefined by science for its role in combating ...

Harbour BioMed (HKEX: 02142), a global biopharmaceutical company focused on the discovery and development of novel antibody therapeutics in immunology and oncology, today announced the launch of its ...

Integrated analyses of the Phase 2 PAISLEY-SLE and PAISLEY LTE studies showed that Sotyktu maintained a consistent safety profile and durable efficacy in patients with moderate-to-severe SLE with up ...

Fake honey is a global concern. New research offers quick tests to spot cheaper materials mixed into pure honey. Scientists ...

In two replicate Phase 3 studies, upadacitinib (RINVOQ ® ) achieved the co-primary endpoints of 50% reduction in Total Vitiligo Area Scoring Index (T-VASI 50) from baseline and 75% reduction in Facial ...

Objective: To describe the joint manifestations associated with clonal haematopoiesis and to compare patients with and ...

Objective To investigate the association between peripheral disease activity and pre-eclampsia, gestational hypertension, ...